Teva’s Patents Infringed, U.S. Judge Rules

Patent claims that Teva Pharmaceutical Industries Ltd. brought against Novartis AG’s Sandoz unit, Mylan Inc. and Momenta Pharmaceuticals Inc. are infringed, valid and enforceable, a federal judge ruled.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.